236 related articles for article (PubMed ID: 11085667)
1. A juvenile case of overlap syndrome of systemic lupus erythematosus and polymyositis, later accompanied by systemic sclerosis with the development of anti-Scl 70 and anti-Ku antibodies.
Nitta Y; Muramatsu M
Pediatr Dermatol; 2000; 17(5):381-3. PubMed ID: 11085667
[TBL] [Abstract][Full Text] [Related]
2. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma-polymyositis overlap syndrome associated with anti-Ku antibody and rimmed vacuole formation.
Yamanishi Y; Maeda H; Katayama S; Ishioka S; Yamakido M
J Rheumatol; 1996 Nov; 23(11):1991-4. PubMed ID: 8923381
[TBL] [Abstract][Full Text] [Related]
4. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic tests: Anti-Ku antibodies].
Suwa A
Nihon Rinsho; 2005 Jul; 63 Suppl 7():523-5. PubMed ID: 16111320
[No Abstract] [Full Text] [Related]
6. Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.
Mahler M; Swart A; Wu J; Szmyrka-Kaczmarek M; Senécal JL; Troyanov Y; Hanly JG; Fritzler MJ
Lupus; 2016 Jul; 25(8):889-96. PubMed ID: 27252266
[TBL] [Abstract][Full Text] [Related]
7. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Ku antibodies].
Suwa A; Mimori T
Nihon Rinsho; 1999 Nov; 57 Suppl():450-2. PubMed ID: 10635880
[No Abstract] [Full Text] [Related]
9. Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report.
Lin KH; Kao JK
Pediatr Rheumatol Online J; 2022 Oct; 20(1):92. PubMed ID: 36271381
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anti-Ku autoantibodies--a serologic marker of overlap syndrome?
Mimori T
Intern Med; 2002 Dec; 41(12):1096-8. PubMed ID: 12521194
[No Abstract] [Full Text] [Related]
11. Anti-Ku autoantibodies: series of 5 cases.
Gryga K; Milewski M; Zółciński M; Dyczek A; Musiał J
Pol Arch Med Wewn; 2009; 119(1-2):95-7. PubMed ID: 19341186
[TBL] [Abstract][Full Text] [Related]
12. Camptocormia as a clinical manifestation of polymyositis/systemic sclerosis overlap myositis associated with anti-Ku.
Zenone T; Streichenberger N; Puget M
Rheumatol Int; 2013 Sep; 33(9):2411-5. PubMed ID: 22453528
[TBL] [Abstract][Full Text] [Related]
13. International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis.
Lakota K; Thallinger GG; Sodin-Semrl S; Rozman B; Ambrozic A; Tomsic M; Praprotnik S; Cucnik S; Mrak-Poljsak K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Czirják L; Varjú C; Steiner G; Aringer M; Stamenkovic B; Distler O; Matucci-Cerinic M; Kveder T
Arthritis Res Ther; 2012 Jan; 14(1):R2. PubMed ID: 22226402
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.
Aguila LA; Lopes MR; Pretti FZ; Sampaio-Barros PD; Carlos de Souza FH; Borba EF; Shinjo SK
Clin Rheumatol; 2014 Aug; 33(8):1093-8. PubMed ID: 24989017
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ku antibodies in connective tissue diseases. Report of three cases.
Parodi A; Rebora A
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):433-5. PubMed ID: 2787812
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies in systemic sclerosis: clinical interest and diagnosis approach].
Admou B; Essaadouni L; Amal S; Arji N; Chabaa L; El Aouad R
Ann Biol Clin (Paris); 2009; 67(3):273-81. PubMed ID: 19411229
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
[TBL] [Abstract][Full Text] [Related]
19. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
[TBL] [Abstract][Full Text] [Related]
20. Clinical and serological associations of anti-Ku antibody.
Cooley HM; Melny BJ; Gleeson R; Greco T; Kay TW
J Rheumatol; 1999 Mar; 26(3):563-7. PubMed ID: 10090163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
